Make prescribing decisions with our comparative charts and treatment algorithms.
Quickly and accurately perform clinical calculations.
Download or print easy-to-read disease leaflets for your patients.
Get valuable insight on select drug products and medically-relevant topics, courtesy of the pharmaceutical industry.
Patients with rheumatoid arthritis experience significantly less psychological stress and physical disability compared with two decades ago, which may be partially due to a reduction in disease activity.
Improvement in functionality, reduction in pain for athletes with Achilles or patellar tendinosis were seen.
The FDA has accepted the New Drug Application (NDA) for Zalviso (sufentanil sublingual microtablet system; AcelRx) for the management of moderate-to-severe acute pain in adult patients in the hospital setting.
The addition of gabapentin to patient-controlled analgesia (PCA) protocol does not reduce morphine consumption, pain, or opioid-related side effects in patients undergoing total knee arthroplasty.
The FDA has accepted for review a New Drug Application (NDA) for Targiniq ER (oxycodone HCl/naloxone HCl controlled-release; Purdue Pharma) Tablets (CII) for the management of chronic pain.
This program will discuss the causes of chronic pain as well as pharmacological options for treating patients with ...3.00 CE for Nurses
The goals of this program are to improve management of spinal disorders. This program is from the 6th ...2.00 AMA PRA Category 1 Credit(s)TM
The objectives of this activity will be to help primary care providers better recognize psychosocial factors in chronic ...1.00 AMA PRA Category 1 Credit(s)TM